纤维细胞生长因子19的横截面和门德尔随机化研究揭示了与代谢疾病的因果关系
Yan Li1,2, Changyong Dai3, Haiqing Yang1
1Graduate School, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Journal of gastroenterology and hepatology
|August 2, 2024
概括
较低的纤维细胞生长因子19 (FGF19) 水平与非酒精性脂肪肝疾病和肥胖症有关. 门德尔随机化表明,FGF19因果改善肝功能和脂质,降低心血管疾病和肝硬化风险.
科学领域:
- 代谢性疾病研究研究.
- 遗传学和个性化医学
- 发现生物标志物的发现.
背景情况:
- 纤维细胞生长因子19 (FGF19) 是一种重要的肠道激素,参与新陈代谢调节.
- FGF19信号的失调与各种代谢疾病有关.
- 了解FGF19的作用对于开发向疗法至关重要.
研究的目的:
- 为了比较不同患者子组的循环FGF19水平.
- 使用孟德尔随机化 (MR) 调查FGF19和代谢性疾病之间的因果关系.
主要方法:
- 对958名参与者进行横截面研究,以比较FGF19水平.
- 使用公开可用的GWAS总结统计数据进行双样本的门德尔随机化分析.
- 研究了基因预测的FGF19与代谢/肝脏生物标志物和疾病之间的关联.
主要成果:
- 在非酒精性脂肪性肝病 (NAFLD) 和肥胖患者中,循环FGF19水平显著降低.
- 基因预测较高的FGF19水平与改善的肝酶 (AST,GGT),脂质样本 (三糖,总胆固醇,LDL) 和降低的C反应蛋白相关.
- FGF19与心血管疾病和肝硬化有负相关性,但与2型糖尿病有正相关性.
结论:
- 较低的FGF19水平与NAFLD和肥胖有关.
- 核磁共振分析支持FGF19在改善肝功能,脂质配置文件以及降低炎症和心血管疾病风险方面起因作用.
- 与2型糖尿病的正相关性可能反映出FGF19耐药性的补偿机制.
更多相关视频
09:52A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
Published on: September 20, 2016
10.3K
06:35A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
Published on: December 22, 2020
4.4K
相关概念视频
Introduction to Fibroblasts
3.1K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.1K
Overview of Lipid Metabolism
1.3K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.3K
Cystic Fibrosis: Pathogenesis
202
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
202
Overview of Carbohydrate Metabolism
845
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
845
Genome-wide Association Studies-GWAS
13.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.3K
